TG2 in ECM associates with integrins inducing activation of anti-apoptotic protein Bcl-2, focal adhesion kinase (FAK) dependent signal transduction pathways including PI3K/Akt, and Ras/Erk, pathways which contribute to cancer aggressiveness [46]. The gene discussed is AKT1; the disease is cancer.